Read + Share
Amedeo Smart
Independent Medical Education
. Correction for Yang et al., Superenhancer drives a tumor-specific splicing variant of MARCO to promote triple-negative breast cancer progression. Proc Natl Acad Sci U S A 2026;123:e2626420123.PMID: 42607226
Email
LinkedIn
Privacy Policy